APTV plunged -14.50% to approximately $48.93 during Tuesday's regular session, with the selloff igniting in premarket trading where shares had already dropped -11.9% following the company's Q2 2026 earnings release. Q2 adjusted EPS of $1.63 handily beat the $1.42 consensus and revenue of $3.3 billion met estimates, but the earnings beat was completely overshadowed by a sharp cut to full-year guidance.

CIFR plunged -12.5% during Tuesday's regular session after trading down roughly -9% in the premarket, driven by a severe Q2 earnings miss. The company reported Q2 revenue of $24.8 million ($32.5M expected), EPS of -$0.65 (-$0.23 expected), and an adjusted EBITDA loss of $30 million, far below the estimated +$218.7 million.

STRL is down approximately -14% during Tuesday's regular session, extending a -4.7% after-hours decline following its Q2 2026 earnings release on August 3. Q2 results were objectively strong — revenue surged +90% YoY to $1.17B and adjusted EPS more than doubled to $5.80 — but the market fixated on margin pressures.

FIS shares plunged -10.07% to $40.27 during Tuesday's regular session after falling more than -10% in premarket trading, following the company's Q2 2026 earnings report and sharply reduced forward guidance. The company slashed its full-year 2026 adjusted EPS forecast to $6.15–$6.24 from $6.22–$6.32 and cut its revenue outlook to $13.63B–$13.70B from $13.77B–$13.85B, with both Q3 EPS and revenue guidance also coming in below consensus.

Target in focus: Piper Sandler's $77 price target represents roughly 40% upside from Moderna's recent close of $55.14, making it the most bullish Wall Street objective currently on the table. Strongest bullish factors: An imminent FDA decision on the company's mRNA flu vaccine (mFLUSIVA), advancing oncology pipeline assets including the closely watched intismeran autogene melanoma program, and a fortified balance sheet with approximately $5.96 billion in pro forma cash.

FTAI Aviation shares have pulled back roughly 9% over the past 30 days, retreating from approximately $248 to the $225 area, following a second-quarter earnings report that missed consensus EPS estimates despite record quarterly revenue. The company reported Q2 2026 revenue of $953 million, up 40.9% year-over-year, while adjusted EPS of $1.13 came in below the $1.32 analyst consensus, triggering post-earnings selling pressure.

Price target: $450 represents a new all-time high for MasTec, surpassing the previous record of $437.51 set in May 2026, and sits within the upper range of analyst forecasts. Bullish case: A record $18.96 billion backlog, accelerating data center and power grid investments, and a consensus "Strong Buy" rating from 20 analysts provide a credible foundation for the recovery narrative.

AST SpaceMobile shares fell approximately 25% over the last 30 days, driven primarily by a $1 billion convertible notes offering that reignited dilution and cash-burn concerns. The broader space sector selloff — amplified by SPCX trading below its IPO price — added significant downward pressure across direct-to-device satellite peers.

Roblox shares plunged approximately 34% over the past 30 days, closing at $36.67 on August 3, 2026, following a disastrous Q2 earnings report and weak forward guidance. The company reported second-quarter bookings of $1.56 billion, up only 8% year-over-year, while forecasting a 14–18% decline in Q3 bookings — well below Wall Street expectations.

Price Target: The $80 level represents the consensus analyst price target for GlobalFoundries (NASDAQ: GFS) — roughly 60% above the stock's recent close near $50, and a level the stock previously surpassed during its May 2026 rally to $92.55. Strongest Bullish Factors: Growing AI-driven demand for mature-node chips, the $300 million CHIPS Act R&D award for silicon photonics, a recent acquisition of Synopsys' Processor IP Solutions business, and a consistent track record of earnings beats provide a solid fundamental foundation.

Alnylam Pharmaceuticals (ALNY) shares plunged approximately 29.6% over the past 30 days, falling from $312.78 on July 2 to $220.33 as of the latest close on August 3, 2026. The primary catalyst was the company's July 30 Q2 2026 earnings report, which featured a $200 million cut to full-year TTR product revenue guidance, triggering a single-day selloff of roughly 28%.

The $350 target represents the highest Wall Street price objective for CRDO, set by Stifel Nicolaus, implying roughly 60% upside from the latest closing price near $218. Explosive revenue growth anchors the bull case — fiscal 2026 revenue more than tripled to $1.335 billion, driven by surging demand for AI data-center connectivity solutions.

Rocket Lab Corporation (RKLB) closed at $70.43 on August 3, 2026, down approximately 53% from its May 2026 all-time high of $151.00, meaning the stock would need to more than double to reclaim the $150 level. The strongest bullish case rests on a record $2.2 billion backlog, accelerating revenue growth above 60% year-over-year, the upcoming Neutron medium-lift rocket, and the transformative $8 billion acquisition of IRDM (Iridium Communications).

Flex Ltd. (NASDAQ: FLEX) closed at $117.45 on August 3, 2026, leaving a roughly 28% climb needed to reclaim the $150 level following a sharp pullback from its all-time high near $162. The planned spin-off of Flex's Cloud and Power Infrastructure business into a separate publicly traded entity remains the single most powerful catalyst, targeting the booming AI data center market with projected revenue growth exceeding 65% in fiscal 2027.

Coherent Corp. (COHR) shares fell approximately 13.6% over the past 30 days, closing at $288.14 on August 3, 2026, down from $333.36 on July 2, as a sector-wide AI photonics selloff accelerated. The decline is part of a broader retreat from the stock's 52-week high of $440.00 reached on June 3, 2026, driven by profit-taking, valuation compression, and cooling sentiment toward high-beta AI hardware names.

Nebius Group shares closed at $212.58 on August 3, 2026, reflecting a modest 1.4% decline over the prior 30 days but masking extreme intra-period volatility that saw the stock swing between roughly $148 and $261. First-quarter 2026 revenue surged 684% year-over-year to $399 million, comfortably beating analyst estimates and reinforcing the company's position as one of the fastest-growing AI neocloud providers.

AAOI shares have declined roughly 8.9% over the past 30 days, a relatively contained pullback compared with the stock's nearly 52% drop from its May 2026 peak of $233.67. The company is scheduled to report second-quarter 2026 results on August 6, with guidance pointing to revenue between $180 million and $198 million and non-GAAP EPS ranging from -$0.03 to $0.03.

Price Target: $500 per share, a major psychological resistance level that Astera Labs nearly touched at its 52-week high of $499.48 but has not yet sustainably breached. Bullish Catalysts: Explosive revenue growth of 93% year-over-year in Q1 2026, the ramp of the Scorpio X-Series 320-lane AI fabric switch, PCIe Gen 6 adoption exceeding one-third of total revenue, and exceptional gross margins above 76%.

Teradyne shares closed at $365.80 on August 3, 2026, roughly flat compared to 30 days prior, but the stock experienced extreme intra-period swings including a sharp sell-off from its $487.91 June high and a dramatic post-earnings recovery. Second-quarter 2026 revenue more than doubled year-over-year to $1.33 billion, with non-GAAP EPS of $2.47 beating consensus estimates by a wide margin, driven by surging AI-related semiconductor test demand.

ON Semiconductor (onsemi) reported Q2 2026 revenue of $1.60 billion , up 9% year-over-year and exceeding the consensus estimate of $1.59 billion. Non-GAAP (Non-GAAP, or adjusted, excludes certain one-time and non-cash items) earnings per share came in at $0.74 , beating analyst expectations of $0.71–$0.72 by approximately 3–4%.